Cision Newshttps://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Thu, 18 Jun 2026 21:47:21 GMTCision News14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pngRESULTS FROM LUNG TRANSPLANT DRUG THERAPY TRIAL REVEAL EXPECTED BUT APPEALING FINDINGShttp://news.cision.com/the-international-society-for-heart-and-lung-transplantation--ishlt-/r/results-from-lung-transplant-drug-therapy-trial-reveal-expected-but-appealing-findings,c9249020cision482645Fri, 20 Apr 2012 15:00:00 GMTINTERNATIONAL EXPERTS ADDRESS CHALLENGES OF DRUG-RESISTANT INFECTION IN HEART AND LUNG TRANSPLANT POPULATIONhttp://news.cision.com/the-international-society-for-heart-and-lung-transplantation--ishlt-/r/international-experts-address-challenges-of-drug-resistant-infection-in-heart-and-lung-transplant-po,c9249017cision482481Fri, 20 Apr 2012 11:00:00 GMTNEW DATA RELEASED AT ISHLT MEETING MAY IMPACT TREATMENT FOR PATIENTS WITH PULMONARY ARTERIAL HYPERTENSIONhttp://news.cision.com/the-international-society-for-heart-and-lung-transplantation--ishlt-/r/new-data-released-at-ishlt-meeting-may-impact-treatment-for-patients-with-pulmonary-arterial-hyperte,c9248309cision481971Thu, 19 Apr 2012 13:00:00 GMTINTERMACS DATA SHOWS PROGRESS USING MCS DEVICES IN DESTINATION THERAPY AS A PERMANENT TREATMENT OPTION FOR HEART FAILUREhttp://news.cision.com/the-international-society-for-heart-and-lung-transplantation--ishlt-/r/intermacs-data-shows-progress-using-mcs-devices-in-destination-therapy-as-a-permanent-treatment-opti,c9247546cision481457Wed, 18 Apr 2012 15:00:00 GMT